Photothermal therapy generates a thermal window of immunogenic cell death in neuroblastoma

Nanoparticle-based photothermal therapy (PTT) has been widely investigated in cancer therapy as a rapid and minimally invasive tumor ablation technique. Over the past two decades, several reports utilizing nanoparticles for PTT of diverse tumor types in vitro and in vivo have been described. An emerging area of interest is the effect of PTT on the immune system during tumor therapy, since PTT not only causes tumor cell death, but can also release tumor antigens and endogenous adjuvants (e.g. heat shock proteins, damage-associated molecular patterns (DAMPs)) under certain conditions. These effects have the potential to increase tumor immunogenicity, which can trigger improved therapeutic responses. Engaging the immune system during PTT is important as it offers the potential for persistent treatment responses and immunological memory. Here, we describe a thermal “window” of immunogenic cell death (ICD) elicited by nanoparticle-based photothermal therapy (PTT) in an animal model of neuroblastoma. Please click Additional Files below to see the full abstract

Data Descriptor: Ash leaf metabolomes reveal differences between trees tolerant and susceptible to ash dieback disease

CMS was funded by the ‘Nornex’ project jointly by UK BBSRC (BBS/E/J/000CA5323) and DEFRA and a BBSRC Tools and Resources grant (BB/N021452/1) awarded to M.G. and D.J.S

Enterovirus specific anti-peptide antibodies

Enterovirus 71 (EV-71) is the main causative agent of hand, foot, and mouth disease (HFMD) which is generally regarded as a mild childhood disease. In recent years, EV71 has emerged as a significant pathogen capable of causing high mortalities and severe neurological complications in large outbreaks in Asia. A formalin-inactivated EV71 whole virus vaccine has completed phase III trial in China but is currently unavailable clinically. The high cost of manufacturing and supply problems may limit practical implementations in developing countries. Synthetic peptides representing the native primary structure of the viral immunogen which is able to elicit neutralizing antibodies can be made readily and is cost effective. However, it is necessary to conjugate short synthetic peptides to carrier proteins to enhance their immunogenicity. This review describes the production of cross-neutralizing anti-peptide antibodies in response to immunization with synthetic peptides selected from in silico analysis, generation of B-cell epitopes of EV71 conjugated to a promiscuous T-cell epitope from Poliovirus, and evaluation of the neutralizing activities of the anti-peptide antibodies. Besides neutralizing EV71 in vitro, the neutralizing antibodies were cross-reactive against several Enteroviruses including CVA16, CVB4, CVB6, and ECHO13

Hydrothermal Synthesis of Cr2Se3 Hexagons for Sensitive and Lowlevel Detection of 4-Nitrophenol in Water

We report a simple hydrothermal method used for the synthesis of Cr2Se3 hexagons (h-Cr2Se3) and its application towards electrochemical sensing of 4-nitrophenol (4-NP). The formation of h-Cr2Se3 was confrmed by using scanning electron microscopy, energy dispersive X-ray spectroscopy, X-ray difraction, and X-ray photoelectron spectroscopy. The electrochemical activity of the h-Cr2Se3 modifed screen-printed carbon electrode (SPCE) towards 4-NP was studied using cyclic voltammetry (CV) and amperometric i-t techniques. Typically,the obtained results were compared with those for a bare SPCE. The CV result clearly reveals that h-Cr2Se3 modifed SPCE has higher catalytic activity towards reduction of 4-NP than bare SPCE. Hence, h-Cr2Se3 modifed SPCE was concluded as a viable sensor for sensitive determination of 4-NP. Under optimized conditions, h-Cr2Se3 modifed SPCE demonstrates the excellent capacity to detect the 4-NP in a linear range from 0.05µM to 908.0µM. The LOD and sensitivity in detection of 4-NP were determined at 0.01µM and 1.24µAµM−1 cm−2 respectively. The sensor is highly selective and stable and shows reproducible recovery of 4-NP in domestic supply and river water samples

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead